Literature DB >> 30017796

Seroprevalence of severe fever with thrombocytopenia syndrome (SFTS) virus antibodies in humans and animals in Ehime prefecture, Japan, an endemic region of SFTS.

Toshiya Kimura1, Aiko Fukuma2, Masayuki Shimojima3, Yasutaka Yamashita4, Fumi Mizota4, Mayumi Yamashita5, Yuka Otsuka6, Miki Kan7, Shuetsu Fukushi8, Hideki Tani9, Satoshi Taniguchi10, Momoko Ogata11, Takeshi Kurosu12, Shigeru Morikawa13, Masayuki Saijo14, Hiroto Shinomiya15.   

Abstract

Severe fever with thrombocytopenia syndrome (SFTS) was first identified as an emerging tick-borne infectious disease caused by the SFTS virus (SFTSV) in China and has also been found to be endemic to Japan and South Korea, indicating that SFTS is of great concern in East Asia. The aim of the present study was to determine the seroprevalence of SFTSV antibodies in humans and animals in SFTS-endemic regions of Japan. One of 694 (0.14%) healthy persons over 50 years of age and 20 of 107 (18.7%) wild and domestic animals in Ehime prefecture of western Japan were determined to be seropositive for SFTSV antibodies by virus neutralization test and ELISA, respectively. The seropositive person, a healthy 74-year-old woman, was a resident of the southwest part of Ehime prefecture engaged in citriculture and field work. This woman's sample exhibited neutralizing activity against SFTSV although she had neither a clear experience with tick bites nor SFTS-like clinical illness. These findings indicate that most people living in the endemic regions are not infected with SFTSV and suggest that most of the SFTS patients reported so far do not reflect the tip of an iceberg of people infected with SFTSV, but at the same time, that SFTSV infection does not always induce severe SFTS-associated symptoms. These findings also suggested that SFTSV has been maintained in nature within animal species and ticks.
Copyright © 2018 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Seroprevalence; Severe fever with thrombocytopenia syndrome; Tick-borne infectious diseases; Zoonosis

Mesh:

Substances:

Year:  2018        PMID: 30017796     DOI: 10.1016/j.jiac.2018.06.007

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  22 in total

1.  Seasonal activity of Haemaphysalis longicornis and Haemaphysalis flava (Acari: Ixodida), vectors of severe fever with thrombocytopenia syndrome (SFTS) virus, and their SFTS virus harboring rates in Gyeonggi Province, South Korea.

Authors:  Hong Geun Kim; Minhyung Jung; Doo-Hyung Lee
Journal:  Exp Appl Acarol       Date:  2022-06-29       Impact factor: 2.380

2.  Distribution of Severe Fever with Thrombocytopenia Syndrome Virus and Antiviral Antibodies in Wild and Domestic Animals in Oita Prefecture, Japan.

Authors:  Takehiro Hashimoto; Takaaki Yahiro; Kentaro Yamada; Kazunori Kimitsuki; Minami W Okuyama; Akiko Honda; Miki Kato; Hiroshi Narimatsu; Kazufumi Hiramatsu; Akira Nishizono
Journal:  Am J Trop Med Hyg       Date:  2022-02-28       Impact factor: 3.707

Review 3.  Severe fever with thrombocytopenia syndrome virus: emerging novel phlebovirus and their control strategy.

Authors:  Mark Anthony Casel; Su Jin Park; Young Ki Choi
Journal:  Exp Mol Med       Date:  2021-05-06       Impact factor: 8.718

4.  Seroprevalence of Severe Fever with Thrombocytopenia Syndrome Virus in Small-Animal Veterinarians and Nurses in the Japanese Prefecture with the Highest Case Load.

Authors:  Yumi Kirino; Keita Ishijima; Miho Miura; Taro Nomachi; Eugene Mazimpaka; Putu Eka Sudaryatma; Atsushi Yamanaka; Ken Maeda; Takayuki Sugimoto; Akatsuki Saito; Hirohisa Mekata; Tamaki Okabayashi
Journal:  Viruses       Date:  2021-02-02       Impact factor: 5.048

5.  Meteorological factors and tick density affect the dynamics of SFTS in jiangsu province, China.

Authors:  Bin Deng; Jia Rui; Shu-Yi Liang; Zhi-Feng Li; Kangguo Li; Shengnan Lin; Li Luo; Jingwen Xu; Weikang Liu; Jiefeng Huang; Hongjie Wei; Tianlong Yang; Chan Liu; Zhuoyang Li; Peihua Li; Zeyu Zhao; Yao Wang; Meng Yang; Yuanzhao Zhu; Xingchun Liu; Nan Zhang; Xiao-Qing Cheng; Xiao-Chen Wang; Jian-Li Hu; Tianmu Chen
Journal:  PLoS Negl Trop Dis       Date:  2022-05-09

6.  Why does activated partial thromboplastin time prolongation occur in severe fever with thrombocytopenia syndrome?

Authors:  Atsushi Mizoe; Junya Sakaue; Noriko Takahara
Journal:  BMJ Case Rep       Date:  2020-10-08

7.  Serologic Evidence of Severe Fever with Thrombocytopenia Syndrome Virus and Related Viruses in Pakistan.

Authors:  Ali Zohaib; Jingyuan Zhang; Muhammad Saqib; Muhammad Ammar Athar; Muhammad Hammad Hussain; Jing Chen; Awais-Ur-Rahman Sial; M Haleem Tayyab; Murrafa Batool; Saeed Khan; Yun Luo; Cecilia Waruhiu; Zeeshan Taj; Zulfiqar Hayder; Riaz Ahmed; Abu Bakr Siddique; Xinglou Yang; Muhammad Asif Qureshi; Ikram Uddin Ujjan; Amanullah Lail; Iahtasham Khan; Tao Zhang; Fei Deng; Zhengli Shi; Shu Shen
Journal:  Emerg Infect Dis       Date:  2020-07       Impact factor: 6.883

Review 8.  Severe fever and thrombocytopenia syndrome virus infection: Considerations for vaccine evaluation of a rare disease.

Authors:  Joel N Maslow; Jackie J Kwon; Susan K Mikota; Susan Spruill; Youngran Cho; Moonsup Jeong
Journal:  Hum Vaccin Immunother       Date:  2019-07-16       Impact factor: 3.452

9.  The first discovery of severe fever with thrombocytopenia syndrome virus in Taiwan.

Authors:  Tsai-Lu Lin; Shan-Chia Ou; Ken Maeda; Hiroshi Shimoda; Jacky Peng-Wen Chan; Wu-Chun Tu; Wei-Li Hsu; Chi-Chung Chou
Journal:  Emerg Microbes Infect       Date:  2020-01-10       Impact factor: 7.163

Review 10.  Factors and outcomes in Severe Fever with Thrombocytopenia Syndrome (SFTS): A systematic review.

Authors:  Herwati Dualis; Abraham Chin Zefong; Lim Kai Joo; Narinderjeet Kaur Dadar Singh; Syed Sharizman Syed Abdul Rahim; Richard Avoi; Mohammad Saffree Jeffree; Mohd Rohaizat Hassan; Mohd Yusof Ibrahim; Azizan Omar
Journal:  Ann Med Surg (Lond)       Date:  2021-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.